Sera Prognostics (SERA) FCF Margin (2020 - 2026)
Sera Prognostics' (SERA) quarterly FCF Margin came in at 62728.57% in Q1 2026, down 4284436.0% YoY from N/an in Q1 2025, and up 2.75% on a QoQ basis from 64500.0% in Q4 2025.
Sera Prognostics (SERA) FCF Margin (2020 - 2026) Analysis & Trends
Sera Prognostics (SERA) has 7 years of FCF Margin data on file, last reported at 62728.57% in Q1 2026.
- Quarterly FCF Margin fell 4284436.0% year-over-year to 62728.57% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 48377.19% (down 2509024.0% YoY) and the FY2025 annual result came in at 32529.63%, down 1402963.0% from the prior year.
- FCF Margin advanced to 62728.57% in Q1 2026, from 64500.0% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 4920.0% in Q1 2023 to a low of 64500.0% in Q4 2025.
- A 5-year average of 25142.74% and a median of 22047.28% in 2024 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2022 — FCF Margin jumped 3176652 bps — and 2026, when it plunged 4284436 bps.
- Tracing SERA's FCF Margin over 5 years: stood at 11432.31% in 2022, then tumbled by 45 bps to 16539.02% in 2023, then slumped by 58 bps to 26116.67% in 2024, then plunged by 147 bps to 64500.0% in 2025, then grew by 3 bps to 62728.57% in 2026.
- The last three FCF Margin figures came in at 62728.57% (Q1 2026), 64500.0% (Q4 2025), and 41181.25% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 15.81% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 16.07% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 23.50% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 33.60% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 14.10% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 1.28% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 5.32% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 18.73% |
| 10 | Sera Prognostics | 103.48 Mn | 103.48 Mn | -20,000.00 | -21,090.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -21,090.00% |
| Mar 31, 2026 | -62,728.57% |
| Dec 31, 2025 | -64,500.00% |
| Sep 30, 2025 | -41,181.25% |
| Jun 30, 2025 | -33,847.06% |
| Mar 31, 2025 | -19,884.21% |
| Dec 31, 2024 | -26,116.67% |
| Sep 30, 2024 | -24,210.34% |
| Jun 30, 2024 | -24,729.17% |
| Dec 31, 2023 | -16,539.02% |
| Sep 30, 2023 | -18,142.86% |
| Jun 30, 2023 | -6,500.00% |
| Mar 31, 2023 | -4,920.00% |
| Dec 31, 2022 | -11,432.31% |
| Sep 30, 2022 | -10,516.09% |
| Jun 30, 2022 | -11,867.95% |
| Mar 31, 2022 | -25,168.42% |
| Dec 31, 2021 | -38,080.77% |
| Sep 30, 2021 | -42,282.61% |
| Jun 30, 2021 | -31,615.00% |